The proposal of an unified model for the interpretation of the activity of different classes of beta-adrenergic agents.
作者信息
Ammon H L, Balsamo A, Macchia B, Macchia F, Howe D, Keefe W E
出版信息
Experientia. 1975 Jun 15;31(6):644-6. doi: 10.1007/BF01944605.
PMID:237775
Abstract
摘要
相似文献
1
The proposal of an unified model for the interpretation of the activity of different classes of beta-adrenergic agents.关于解释不同类别β-肾上腺素能药物活性的统一模型的提议。
Experientia. 1975 Jun 15;31(6):644-6. doi: 10.1007/BF01944605.
2
Binding of agonists and antagonists to beta-adrenergic receptor.激动剂和拮抗剂与β-肾上腺素能受体的结合。
Prog Clin Biol Res. 1989;291:275-80.
3
Molecular geometry and binding capacity in the series of beta-adrenergic compounds.β-肾上腺素能化合物系列中的分子几何结构与结合能力
Farmaco Sci. 1975 May;30(5):315-25.
4
Beta-adrenergic drugs: analysis of crystallographic and theoretical results.β-肾上腺素能药物：晶体学和理论结果分析
Mol Pharmacol. 1980 May;17(3):339-43.
5
Structure-binding-activity analysis of beta-adrenergic amines--II. Binding to the beta receptor and inhibition of adenylate cyclase.β-肾上腺素能胺的结构-结合-活性分析——II. 与β受体的结合及对腺苷酸环化酶的抑制作用
Biochem Pharmacol. 1978 May 15;27(10):1455-61. doi: 10.1016/0006-2952(78)90101-6.
6
Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor.激动剂和拮抗剂与β-肾上腺素能受体分子相互作用的根本差异。
Nature. 1979 Sep 13;281(5727):114-7. doi: 10.1038/281114a0.
7
Structure-binding-activity analysis of beta-adrenergic amines--I. Binding to the beta receptor and activation of adenylate cyclase.β-肾上腺素能胺的结构-结合-活性分析——I. 与β受体的结合及腺苷酸环化酶的激活
Biochem Pharmacol. 1978 May 15;27(10):1445-54. doi: 10.1016/0006-2952(78)90100-4.
8
Three-dimensional models for beta-adrenergic receptor complexes with agonists and antagonists.β-肾上腺素能受体与激动剂和拮抗剂复合物的三维模型。
J Med Chem. 2003 Oct 9;46(21):4450-62. doi: 10.1021/jm0301437.
9
Ligand binding model for G-protein-linked receptors: an update.
Drug Des Discov. 1993;9(3-4):213-20.
10
Structural basis for the β-adrenergic receptor subtype selectivity of the representative agonists and antagonists.β-肾上腺素受体亚型选择性的代表性激动剂和拮抗剂的结构基础。
J Chem Inf Model. 2011 Jun 27;51(6):1405-22. doi: 10.1021/ci2000874. Epub 2011 May 13.
本文引用的文献
1
The structure of the catecholamines. I. The crystal structure of noradrenaline hydrochloride.儿茶酚胺的结构。I. 盐酸去甲肾上腺素的晶体结构。
Acta Crystallogr. 1967 Aug 10;23(2):313-9. doi: 10.1107/s0365110x67002646.
2
The crystal structure of dl-isoproterenol sulfate dihydrate.硫酸二水合dl-异丙肾上腺素的晶体结构。
J Am Chem Soc. 1971 Jan 27;93(2):497-502. doi: 10.1021/ja00731a032.
3
The structure-activity relationships of beta adrenergic drugs and beta adrenergic blocking drugs.β肾上腺素能药物与β肾上腺素能阻断药物的构效关系。
Ann N Y Acad Sci. 1967 Feb 10;139(3):606-31. doi: 10.1111/j.1749-6632.1967.tb41232.x.
4
The beta-adrenergic blocking agents pharmacology and structure-activity relationships.β-肾上腺素能阻滞剂的药理学及构效关系。
Fortschr Arzneimittelforsch. 1966;10:46-89. doi: 10.1007/978-3-0348-7059-7_3.
5
Conformational and phosphate binding properties of phenylethanolamines. Crystal structure of ephedrine monohydrogen phosphate monohydrate.
J Am Chem Soc. 1973 Oct 17;95(21):7150-4. doi: 10.1021/ja00802a041.
6
The conformation of catecholamines and related compounds in solution.溶液中儿茶酚胺及相关化合物的构象
Mol Pharmacol. 1973 Nov;9(6):756-65.
7
X-ray analysis of Th 1165a and salbutamol.钍1165a与沙丁胺醇的X射线分析。
J Pharm Pharmacol. 1972 Apr;24(4):277-80. doi: 10.1111/j.2042-7158.1972.tb08986.x.
8
Structure-activity relationships in the adrenergic-blocking agents.肾上腺素能阻滞剂的构效关系。
J Pharm Sci. 1969 May;58(5):511-38. doi: 10.1002/jps.2600580502.
9
Molecular orbital studies on the mechanism of drug-receptor interaction. 1. Adrenergic drugs. Conformation and reactivity of isoproterenol and 1-(p-nitrophenyl)-2-isopropylaminoethanol.药物-受体相互作用机制的分子轨道研究。1. 肾上腺素能药物。异丙肾上腺素和1-（对硝基苯基）-2-异丙氨基乙醇的构象与反应活性
J Med Chem. 1974 May;17(5):501-7. doi: 10.1021/jm00251a006.
10
1-Alkylamino-3-(2-thiazolyloxy)-2-propanols. A novel class of mixed myocardial beta-stimulants-beta-blockers.
J Med Chem. 1974 Feb;17(2):200-3. doi: 10.1021/jm00248a012.
Zotero 插件